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The authors examined the lung lesions caused by peroral aluminium 
application as a 0,1 % solution of A 1С 13 in a dose of 3 mg Al3+/kg b. w. for 40 
days in a total of 126 white male rats (70 experimental and 56 control). Visible 
structural alterations were established on the 15^ day of the trial consisting in 
desquamation of bronchial epithelium, enhanced pmounts of acid 
glucosaminoglycans in the cell cytoplasm and irregular disposition of cells. 
Later on, the activity of SDH, alkaline phosphatase, and ATF-ase decreased but 
acid phosphatase activity increased. Connective-tissue fibres grew up in the 
wall of some bronchi. These morphological findings suggest that although 
perorally accepted, A 1С 13 induced structural lesions in the lungs as well as 
metabolic disturbances in the bronchial mucosa which depended on the 




peroral application, lungs, histopathology. 
Aluminium is a widespread element. It 
is used in the chemical industry where one 
contacts with its compounds. In the human 
body aluminium (Al) causes different 
organic alterations. Al effect on the tissues 
depends on the way of introduction into the 
organism and the subsequent metabolic 
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processes. Perorally applied A l induces 
structural lesions in the brain, liver, heart, 
kidneys and bones (3, 7, 8, 11 - 13, 15, 
19) . It exerts also an embryotoxic effect (5, 
11, 18) while its inhalation by the bronchial 
tree attacks mainly the lungs (1 , 10, 14, 16, 
20) . 
We could not find any publications 
dealing with lung lesions as a result from 
peroral application of Al or its compounds 
in the literature available. 
The purpose of the present study was 
to reveal the structural alterations in the 
lungs caused by A l administered in 
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application. Multilayered bronchial epithelium. 
Cell nuclei are located in a different distance 
from the basement membrane. Staining HE. 
Mazn. 10x10 
minimal doses and the mechanism of the 
development of these changes. 
M A T E R I A L AND METHODS 
The examination covered 126 white 
male rats with body weight of 120 ± 10 g. 
Some 70 experimental animals were 
perorally given 3 mg /kg of A P + as a 0,1 
% solution of AICI3 for 40 days while the 
control group of 56 rats received distilled 
water during the same period. Ten 
experimental and eight control rats each 
were killed by decapitation on the 5*\ 
10 t h , 15 t h , 20 t h , 25 t h , 30 t h . and 4 0 t h day 
of the trial. Lung pieces were fixed in 10 % 
formalin solution and in Carnua solution as 
well. Paraffin sections (5 \xm tick) were 
stained with HE, after Gomori (for 
reticular fibres), after van Gieson (for 
collagen ftissue), with PAS reaction after 
McManus (for glycoproteins), with 
toluidine blue at pH 2 and pH 4 (for acid 
glucosaminoglycans), with Brachet 
reaction (for RNA) and Feulgen reaction 
(for DNA). The succinate dehydrogenase 
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Fig. 2. Rat lung 40 days after peroral AlC 13 
application. Desquamated bronchial cells and 
uncovered basement membrane. Staining HE. 
Magn. 10x10 
(SDH) activity was estimated on cryostat 
sections after the method of Nachlas. the 
alkaline phosphatase and acid phosphatase 
activity - after that of Gomori, and the 
adenosine triphosphatase (ATP-ase) 
activity - after that of Padycula and 
Herman. 
RESULTS 
We establish visible structural lesions 
in the lungs on the 15 t J l day of the 
experiment. Some single and grouped 
bronchial mucosa cells in the large and 
middle bronchi are desquamated. Remnants 
of the cells cover the basement membrane 
with one or more layers. Nuclei are circled 
or thinned situated in a different distance 
from the basement membrane (Fig. 1). In 
the cytoplasm there is an enhancement of 
mucinous substances such as glycoproteins 
and acid glucosaminoglycans. 
The activity of SDH, ATP-ase and 
alkaline phosphatase remains unchanged. 
Acid phosphatase activity is slightly 
expressed. Reticular and collagen fibres in 
bronchial walls are irregularly thick but 
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Fig. 3. Weak SDH-ase actihity in bronchial 
cells. Left - controls. Alagn. 10x10 
some of them are rather rough. 
Interalveolar septi are focally thickened. 
There is infiltration of lymphocytes, 
plasmocytes and single eosinophils. High 
activity of both alkaline phosphatase and 
ATP-ase is proved in endothelial cells and 
adventitia of blood vessels. Desquamated 
pneumocytes mixed with macrophages with 
high cytoplasmic activity of both alkaline 
and acid phosphatases are observed in the 
lumen of alveolar groups. 
These changes aggravate until the 20^ 
day after treatment. In intact cells there is a 
higher concentration mainly of acid 
glucosaminoglycans while pyroninophilic 
granules are irregularly scattered in the 
cytoplasm being reduced in number in most 
cells. The staining of the nuclei of 
bronchial epithelial cells is of different 
intensity. The activity of S D R ATP-ase 
and alkaline phosphatase is diminished in 
some cells but enhanced in others. Acid 
phosphatase activity is elevated. 
During the interval between the 3()^1 
and 4()t*1 day, desquamation affects a large 
number of epithelial cells of bronchi of 
different caliber and the basal membrane is 
completely uncovered (Fig. 2). The 
Fig. 4. Reduced alkaline phosphatase activity 
(in the square) as compared to that of controls. 
Magn. 10x10 
amounts of glycoproteins, acid 
glucosaminoglycans, nuclear DNA and 
cytoplasmic RNA are significantly reduced 
on the 4 0 t h day after treatment. SDH 
activity is also strongly decreased (Fig. 3) 
being detectable in single bronchial 
epithelial cells and alveolar macrophages 
only. The activity of ATP-ase and acid 
phosphatase varies. Alkaline phosphatase 
activity remains high in vascular walls but 
reduces and even disappears in most 
bronchial epithelial cells and pneumocytes 
as well (Fig. 4). 
In some bronchial walls certain 
inflammatory alterations along with 
growing up of fine peribronchially located 
connective-tissue fibres are observed. 
Alveolar septi are thickened and contain 
lymphocytes, plasmocytes and other cells. 
Desquamated pneumocytes and 
macrophages can be detected in alveolar 
lumens. Focal atelectasis is also present 
(Fig. 5). 
DISCUSSION 
Our morphological findings 
demonstrate that peroral Al administration 
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Fig. 5. Desquamated pneumocytes and 
macrophages in alveolar lumen. Focal 
atelectasis. Staining HE. Magn. lOx 10 
induces structural and functional 
pulmonary disorders. Already on the 15 t h 
day after A l introduction, some signs of 
damage of the epithelial cells of the 
bronchial mucosa can be established. Later 
on the activities of SDH and ATP-ase 
which participate in the oxidative 
phosphorization and cellular preservation 
(9) decrease along with acid phosphatase 
activity enhancement. These changes argue 
convincingly of the development of 
dystrophic processes in the cells and of 
disturbances of cell metabolism. On the 
other hand, there is an intensive mucous 
secretion in the bronchial epithelial cells on 
the account of glycoproteins and 
particularly of acid glucosaminoglycans. 
This is considered an expression of a 
defense reaction against the action of toxic 
substances and their derivatives (2). The 
reduction of mucous substances and, 
especially, that of acid glucosaminoglycans 
established by us at the end of experiment 
is assumed by some authors (6) to 
influence unfavourably upon the 
mechanisms of compensation and 
adaptation of the bronchial mucosa. 
The diminution of alkaline phosphatase 
activity in bronchiolar epithelial cells 
considered like pneumocytes of type 2 the 
most sensitive cells towards toxic 
influences (4) 30 days after the treatment is 
of essential interest. It could be presumed 
that due to aluminium-induced disorders in 
phosphate metabolism (17) the synthesis of 
phospholipids in the pneumocytes of type 2 
is destroyed resulting in altered metabolic 
processes in these cells. 
In contrast to lung alterations after Al 
inhalation characterized by granulomas, 
diffuse pulmonary fibrosis, etc. (1 , 10, 14), 
the changes after peroral A l application 
remain more discrete. It seems possible 
that, however, the alterations in reticular 
fibres such as roughness, fragmentation, 
etc. along with inflammatory changes in the 
wall and peribronchial growing up of thin 
connective-tissue fibres could determine the 
development of bronchial and peribronchial 
fibrosis after Al treatment of a longer 
duration. 
CONCLUSION 
The analysis of our results indicates 
that the development of both structural and 
metabolic disturbances, in the lungs 
depends on the duration of A l treatment. 
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Experimentelle Untersuchung der Aluminiumseinwirkung iiber die 
Struktur und Funktion der Organen der Ratte bei der peroralen 
Applikation. Veranderungen in den Lungen 
E . Softowa, S. Bojadzhiewa, P. Nikolowa*, B. Kavaldzhieva* 
Lehrstuhl fiir allgemeine und klinische Pathologie, *Lehrstuhl for Hygiene und 
Okologie, Medizinische Universitcit Varna 
Zusammenfassung: Es wurde ein Versuch tiber 126 weiBen mannlichen (70 
experimentelle und 56 Kontrolltiere) Ratten angestellt. Das Aluminium wurde 
peroral durch eine Sonde als 0,1 %-ige Losung von AICI3 in einer Dose von 3 mg 
A l ^ / k g innerhalb von 40 Tage lang verabreicht. Man studierte die 
Lungenveranderungen der Ratten. Schon am 15. Tag nach dem Beginn des 
Experiments wurden einige strukturelle Beeintrachtigungen in den Lungen 
festgestellt: eine Desquamation des Bronchialepithels, eine Steigerung der Menge 
der Glukoseaminoglykans im Zytoplasma und eine unregelmaBige Verteilung der 
Zellen. Die Aktivitat der SDH-ase, der alkalischen Phosphatase und der ATP-ase 
nahm ab, wahrend sich diese der sauren Phosphatase erhohte. In der Wand einiger 
Brochi stellte man auBerdem Kollagenfaserwachstum fest. Diese 
morphologischen Veranderungen zeugen davon, daB. obwohl das AICI3 peroral 
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eingenommen wurde, seine Wirkung iiber die Lungen- und Bronchialstruktur 
ausgeubt wurde. Die Schwere dieser Lasionen hing von der Dauer der 
Einwirkung ab. 
Etude experimental sur la structure et la fonction des organes sous 
l'effet de raluminium accepte oralement dans I'organisme. 
Changements dans les poumons des rats 
E . Softova, S. Boiadjieva, P. Nikolova*, B. Kavaldjieva* 
Chaire de pathologie generate et clinique, *Chaire d'hygiene et d'ecologie, 
Universite de medecine a Varna 
Resume: Dans les conditions experimentales on a etudie en dynamique Taction de 
raluminium sur 126 rats blancs males (70 - d'experiment et 56 - de controle). 
L'aluminium a ete admis comme une solution de 0,1 % d fAlCl3 en dose de 3 mg 
Al 3+/ke au cours de 40 jours. On a etudie les changements de la structure des 
poumons. Au 15 е jour du debut du traitement on a examine des changements dans 
les branches - ecaillage des cellules epitheliales de la muqueuse bronchiale, un 
contenu muqueux augmente dans la cytoplasme, un arrangement irregulier des 
cellules, etc. Le caractere de ces changements s'est approfondit au cours de 
Texperiment. On a constate une diminuation de l'activite de la 
succindehydrogenase, de la phosphatase alcaline, de Tadenosine-triphosphatase; 
une augmentation de l'activite de la phosphatase acide; la quantite des substances 
muqueuses diminue, et dans quelques des bronches se developpe une fibrose. Les 
changements nous montrent que AICI3 admis oralement provoque des 
modifications dans la structure des poumons et de changements metaboliques 
dans la muqueuse bronchiale. Ces changements dependent de la continuity du 
traitement 
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